Intraday Info: AC Immune Ltd (NASDAQ:ACIU) locked on 03/02/2017 at $12.14. It has average volume 63,143 whilst it totals volume 43,110. The company has EPS -0.13. Profit Margin of ACIU -31.30% and it total income -7.00 million.
Ownership Summary: AC Immune Ltd has total institutional ownership 14.39% while its total outstanding shares 55 millions that’s value of holdings $97 million.
Active Positions: In the latest year, ACIU 32 holders have raised its positions while it contains total 7,971,611 shares. And the strength of reduced positions holders and held positions holders are 1 and 47,348 respectively.
New and Sold Out Positions: In ACIU force of new positions holders 32 and it has total shares 7,971,611. And force of sold out positions holders 1 and it has 47,348 shares.
Comparison with Other Company: The Market Value of ACIU is $654,844 below from AbbVie Inc. market value which is $98M. Current Last Sale of ACIU is $12.14 below from AbbVie Inc. current last sale which is $60.67.
AC Immune SA designs, discovers, and develops therapeutic and diagnostic merchandise intended to prevent and alter illnesses due to misfolding proteins. The enterprises era systems create antibodies, small molecules, and vaccines to cope with a large spectrum of neurodegenerative indications. It offers its therapies to address Alzheimer ailment and neurodegenerative diseases, consisting of Parkinson, Down syndrome, and glaucoma. AC Immune SA turned into founded in 2003 and is based totally in Lausanne, Switzerland.